TEAS RF New Application

PTO Form 1478 (Rev 9/2006)

OMB No. 0651-0009 (Exp 02/28/2018)

---

PTO Form 1478 (Rev 9/2006)

OMB No. 0651-0009 (Exp 02/28/2018)

Trademark/Service Mark Application, Principal Register

Serial Number: 86690908

Filing Date: 07/13/2015

To the Commissioner for Trademarks:

MARK: INREBIC (Standard Characters, see mark)
The literal element of the mark consists of INREBIC.
The mark consists of standard characters, without claim to any particular font, style, size, or color.

The applicant, Celgene Corporation, a corporation of Delaware, having an address of
      86 Morris Avenue
      Summit, New Jersey 07901
      United States


requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Switzerland application number 58199/2015, filed 07/09/2015.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on §44(e) as a basis for registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.

Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and will submit a copy of Switzerland registration number 58199/2015, and/or proof of renewal, registered 07/09/2015 with a renewal date of 07/09/2025 and an expiration date of 07/09/2025, and translation thereof, if appropriate.


Miscellaneous Statement
Celgene Corporation has a manufacturing facility in Switzerland which manufactures compounds located at Faubourg du Lac 11, 2000 Neuchâtel, Switzerland. Thus, Switzerland is a "country of origin" for Celgene Corporation. Celgene Corporation has a bona fide and effective industrial and commercial establishment in a foreign country.

The applicant's current Attorney Information:
      Camille M. Miller and David M. Albert, Melanie A. Miller, J. Trevor Cloak, Brianne L. Polito, Chanel L. Lattimer of Cozen O'Connor

      IP Department
      1650 Market Street
      Philadelphia, Pennsylvania 19103
      United States
The attorney docket/reference number is 373290/CELG-1386-CH.

The applicant's current Correspondence Information:

Camille M. Miller

Cozen O'Connor

IP Department       1650 Market Street

Philadelphia, Pennsylvania 19103

2156657273(phone)

2157012273(fax)

cmiller@cozen.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant or applicant's attorney at the e-mail address provided above. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in an additional processing fee of $50 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

The signatory believes that: if the applicant is filing the application under 15 U.S.C. § 1051(a), the applicant is the owner of the trademark/service mark sought to be registered; the applicant is using the mark in commerce on or in connection with the goods/services in the application; the specimen(s) shows the mark as used on or in connection with the goods/services in the application; and/or if the applicant filed an application under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e), the applicant is entitled to use the mark in commerce; the applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the goods/services in the application. The signatory believes that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive. The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Camille M. Miller/   Date: 07/13/2015
Signatory's Name: Camille M. Miller
Signatory's Position: attorney
RAM Sale Number: 86690908
RAM Accounting Date: 07/13/2015

Serial Number: 86690908
Internet Transmission Date: Mon Jul 13 12:48:40 EDT 2015
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XXX-2015071312484021
2815-86690908-540c68776ab8a907d9c66fbc6f
3dd4d22b8489f63f414ba69620df7f93c2d30d2-
CC-10286-20150713124227012986